Daré Bioscience, Inc. (DARE)
0.7734
0.00 (0.00%)
USD |
NASDAQ |
Oct 09, 16:00
0.773
0.00 (0.00%)
After-Hours: 20:00
Daré Bioscience Free Cash Flow (Quarterly) : -6.856M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.856M |
| March 31, 2026 | -5.521M |
| December 31, 2025 | 1.238M |
| September 30, 2025 | -0.6168M |
| June 30, 2025 | -5.264M |
| March 31, 2025 | -5.628M |
| September 30, 2024 | -5.642M |
| June 30, 2024 | 12.63M |
| March 31, 2024 | -6.828M |
| December 31, 2023 | -8.786M |
| September 30, 2023 | -7.996M |
| June 30, 2023 | -6.586M |
| March 31, 2023 | -16.12M |
| December 31, 2022 | -5.899M |
| September 30, 2022 | 8.545M |
| June 30, 2022 | -8.449M |
| March 31, 2022 | -12.35M |
| December 31, 2021 | -9.916M |
| September 30, 2021 | 1.306M |
| June 30, 2021 | -11.79M |
| March 31, 2021 | -8.377M |
| December 31, 2020 | -9.196M |
| September 30, 2020 | -5.357M |
| June 30, 2020 | -4.102M |
| March 31, 2020 | -6.598M |
| Date | Value |
|---|---|
| December 31, 2019 | -3.809M |
| September 30, 2019 | -3.180M |
| June 30, 2019 | -3.018M |
| March 31, 2019 | -3.308M |
| December 31, 2018 | -2.710M |
| September 30, 2018 | -2.754M |
| June 30, 2018 | -2.697M |
| March 31, 2018 | -2.119M |
| December 31, 2017 | -0.9611M |
| September 30, 2017 | -1.419M |
| June 30, 2017 | -0.1096M |
| March 31, 2017 | -0.0506M |
| December 31, 2016 | -1.911M |
| September 30, 2016 | -7.187M |
| June 30, 2016 | -11.35M |
| March 31, 2016 | -13.62M |
| December 31, 2015 | -8.346M |
| September 30, 2015 | -8.001M |
| June 30, 2015 | -7.875M |
| March 31, 2015 | -7.97M |
| December 31, 2014 | -5.717M |
| September 30, 2014 | -5.636M |
| June 30, 2014 | -4.253M |
| March 31, 2014 | -3.68M |
| December 31, 2013 | -3.271M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Elite Pharmaceuticals, Inc. | 9.261M |
| Eton Pharmaceuticals, Inc. | 7.26M |
| ANI Pharmaceuticals, Inc. | 53.62M |
| Corcept Therapeutics, Inc. | 31.02M |
| Veru, Inc. | -5.467M |